Welcome to the second installment of the Department of Chemistry and Biochemistry’s alumni newsletter. Much has transpired in the department since the launching of our inaugural newsletter, and I’m delighted to be able to bring you up to date. It’s been a great year for us, marked by a strong cadre of 39 baccalaureate, 19 doctoral, and eight master’s degree recipients. Our faculty corralled an abundance of awards and honors that are detailed below. The department welcomed a new faculty member, but sadly bid farewell to Fr. Walter. We were honored to host the family of Nicholas Angelotti (B.S., 1950), as they helped us launch an undergraduate research fund in his name.
Please know that we here in the department are proud of our alumni and welcome opportunities to learn of your accomplishments. Simply send an email to our assistant chair, Mary Prorok and we will do our best to incorporate items of interest into future newsletters. In the meantime, I wish you an enjoyable remainder of the summer. Stay cool and stay in touch!
Sergei Starchenko, professor of mathematics, was recently named a fellow in the American Mathematical Society for 2017.
Notre Dame doctoral candidate, Nicholas Myers, came second in an elevator pitch contest at the Micronutrient Forum 2016 global conference in Cancun, Mexico. The Micronutrient Forum aims to be a global catalyst and convener for sharing expertise, insights, and experience relevant to micronutrients in all aspects of health promotion and disease prevention. It brings together researchers, professionals, students, organizations, and stakeholders to converse and collaborate in order to end malnutrition worldwide. The particular focus of the 2016 global conference was the positioning of women’s nutrition at the center of sustainable development.
The Flatley Center for Undergraduate Scholarly Engagement (CUSE) at the University of Notre Dame promotes the intellectual development of Notre Dame undergraduates through scholarly engagement, research, creative endeavors, and the pursuit of fellowships. Although CUSE works with over 1,000 Domers each year, not everyone knows about all of its services. CUSE sat down with four senior CUSE Sorin Scholars — Kiley Adams (biological sciences), Ian Tembe (chemical engineering and philosophy), Grace Watkins (philosophy), and Emily Zion (biochemistry) [pictured in order below] — to speak about the benefits that CUSE has provided for them, and why other students should work with CUSE during their time here.
With her ultimate goal of becoming a doctor in mind, Notre Dame junior Candice Park spent this past summer in India for eight weeks, grappling with issues surrounding medicine and public health in New Delhi.
Watkins, a native of Blacksburg, Virginia, and Doyle, of Los Altos, California, are two of 32 Rhodes Scholars selected from a pool of 882 candidates who had been endorsed by their colleges and universities. They are Notre Dame’s 18th and 19th Rhodes Scholars and will commence their studies at Oxford University in October.
Diabetes is a metabolic disease in which the body has an inability to produce enough insulin. In the United States alone, it is estimated that the illness affects nearly 30 million diagnosed and undiagnosed people, and treatment often includes patients using an intravenous or IV method to get insulin into their system. This uncomfortable and inconvenient form of treatment can require anywhere from two to four injections a day, but a Notre Dame researcher is working to combat this problem with a less frequent, oral delivery system.
Each year, FURF allows undergraduate students to showcase the work they have done thus far in their academic careers.
Amanda Hummom learned of the strong genetic component behind cancer, especially colon cancer, affecting the same family over and over again. This is a huge part of why she is committed to studying the molecular mechanisms that fuel the disease. “I don’t want to see my children, or my future grandchildren, develop this disease … I want to help all families facing this disease,” she said.
One in 77 women will develop ovarian cancer in her lifetime. Because ovarian cancer has no defined symptoms, most women will be diagnosed at a late stage of the disease where metastatic lesions are found dispersed throughout the abdomen. Ovarian cancer is currently the fifth most common cause of cancer-related deaths in women. With new technology being developed at the Harper Cancer Research Institute, the ovarian cancer surgery success rate may ultimately improve significantly.